Lupus Resource Center

video

Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE

During the American College of Rheumatology (ACR) Convergence 2020, several presentations discussed data on the use of anifrolumab to treat patients with systemic lupus...
baricitinib

Healthcare Visits, DMARD Treatment Both Interrupted for Autoimmune Rheumatic Patients During COVID-19

The COVID-19 pandemic impacted virtually all areas of health care, whether it be access to medication, conversions to telemedicine, or a number of other...
The Latest Research on Baricitinib, Eli Lilly’s Arthritis Drug Used to Treat COVID-19

The Latest Research on Baricitinib, Eli Lilly’s Arthritis Drug Used to Treat COVID-19

Eli Lilly’s rheumatoid arthritis (RA) drug baricitinib, marketed as Olumiant, has been the subject of several clinical trials in the fight to treat COVID-19....
Doctor consulting with senior male patient.

Why Do Black SLE Patients Have Lower Medication Adherence than White Patients?

Racial disparities among systemic lupus erythematosus (SLE) patients have been documented, with previous research showing poorer incidence, prevalence, and long-term outcomes among racial minorities...
hydroxychloroquine

SLE Patients May Be Able to Safely Discontinue Hydroxychloroquine Without Increasing Flares

Many systemic lupus erythematosus (SLE) patients take hydroxychloroquine to help manage their disease. Benefits of the antimalarial include reduced flares, neonatal lupus risk, and...
trump, Hydroxychloroquine, hip arthroplasty, covid-19, postoperative, cancellations, rheumatologists, voltaren, fracture, opioids, TXA, JIA, pain, disease, frailty, violence, rheumatic, acr, cbd, NSAIDs, humira, knee, TJA

Rheum Round-up: Hydroxychloroquine Still A Flop for COVID-19, Real-World RA Treatment Comparison, and more

Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about more research rejecting hydroxychloroquine as...
covid-19, ra, interview, Rheum Round-up: Europe Rejects EVENITY, Tanezumab vs. Placebo for OA, and More

Rheum Round-up: Interivew with a Rheumatologist, Hydroxychloroquine and COVID-19 Prevention, and more

Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read an interview with a rheumatologist, what...

Curated Journal Reading List